Knockdown of CD24 inhibits proliferation, invasion and sensitizes breast cancer MCF-7 cells to tamoxifen in vitro

European Review for Medical and Pharmacological Sciences

Volumn 19, Issue 13, 2015, Pages 2394-2399

  Ma, Z L ^a   Chen, Y P ^b   Song, J L ^b   Wang, Y Q ^b  

^a QINGDAO UNIVERSITY   (China)

^b Qingdao Women and Children Health Care Centers   (China)

Author keywords

Apoptosis; Breast cancer; CD24; Invasion; Tamoxifen

Indexed keywords

CD24 ANTIGEN; PLASMID VECTOR; SMALL INTERFERING RNA; TAMOXIFEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CD24 PROTEIN, HUMAN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CELL INVASION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG INHIBITION; DRUG SENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MCF 7 CELL LINE; MTT ASSAY; RNA VECTOR; TUNEL ASSAY; WESTERN BLOTTING; BREAST TUMOR; CELL MOTION; DRUG EFFECTS; FEMALE; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; TUMOR INVASION;

ANTIGENS, CD24; ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; MCF-7 CELLS; NEOPLASM INVASIVENESS; RNA, SMALL INTERFERING; TAMOXIFEN;

EID: 84942239491     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. HENNIKER AJ, VILLADSEN R, NIELSEN HL, RONNOVJESSEN L, BISSELL MJ. CD24. J Biol Regul Homeost Agents 2001;15:182-184.
2. SCHABATH H, RUNZ S, JOUMAA S, ALTEVOGT P. CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells. J Cell Sci 2006;119:314-325.
3. JACOB J, BELLACH J, GRÜTZMANN R, ALLDINGER I, PILARSKY C, DIETEL M, KRISTIANSEN G. Expression of CD24 in adenocarcinomas of the pancreas correlates with higher tumor grades. Pancreatology 2004;4:454-460.
4. SU MC, HSU C, KAO HL, JENG YM. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma. Cancer Lett 2006;235:34-39.
5. TANG J, CAI H, LIN L, XIE P, ZHONG W, TANG M. Increased expression of CD24 is associated with tumor progression and prognosis in patients suffering osteosarcoma. Clin Transl Oncol 2013;15:541-547.
6. TAKAHASHI M, NAKAJIMA M, OGATA H, DOMEKI Y, OHTSUKA K, IHARA K, KURAYAMA E, YAMAGUCHI S, SASAKI K, MIYACHI K, KATO H. CD24 expression is associated with progression of gastric cancer. Hepatogastroenterology 2013;60:653-658.
7. KIM K, MIN HS, CHIE EK, JANG JY, KIM SW, HAN SW, OH DY, IM SA, KIM TY, BANG YJ, JANG JJ, HA SW. CD24 expression predicts distant metastasis in extrahepatic bile duct cancer. World J Gastroenterol 2013;19:1438-1443.
8. SHI Y, GONG HL, ZHOU L, TIAN J, WANG Y. CD24: a novel cancer biomarker in laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 2012;74:78-85.
9. DENG J, GAO G, WANG L, WANG T, YU J, ZHAO Z. CD24 expression as a marker for predicting clinical outcome in human gliomas. J Biomed Biotechnol 2012;2012:517172.
10. MILLER E, SHAPIRA S, GUR E, NAUMOV I, KAZANOV D, LESHEM D, BARNEA Y, MESHIACH Y, GAT A, SION D, Arber N, Kraus S. Increased expression of CD24 in nonmelanoma skin cancer. Int J Biol Markers 2012;27:e331-336.
11. CHOI YL, LEE SH, KWON GY, PARK CK, HAN JJ, CHOI JS, CHOI HY, KIM SH, SHIN YK. Overexpression of CD24: association with invasiveness in urothelial carcinoma of the bladder. Arch Pathol Lab Med 2007;131:275-281.
12. YANG XR, XU Y, YU B, ZHOU J, LI JC, QIU SJ, SHI YH, WANG XY, DAI Z, SHI GM, WU B, WU LM, YANG GH, ZHANG BH, QIN WX, FAN J. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery. Clin Cancer Res 2009;15:5518-5527.
13. FOGEL M, FRIEDERICHS J, ZELLER Y, HUSAR M, SMIRNOV A, ROITMAN L, ALTEVOGT P, STHOEGER ZM. Author information. CD24 is a marker for human breast carcinoma. Cancer Lett 1999;143:87-94.
14. ATHANASSIADOU P, GRAPSA D, GONIDI M, ATHANASSIADOU AM, TSIPIS A, PATSOURIS E. CD24 expression has a prognostic impact in breast carcinoma. Pathol Res Pract 2009;205:524-533.
15. KRISTIANSEN G, WINZER KJ, MAYORDOMO E, BELLACH J, SCHLÜNS K, DENKERT C, DAHL E, PILARSKY C, ALTEVOGT P, GUSKI H, DIETEL M. CD24 expression is a new prognostic marker in breast cancer. Clin Cancer Res 2003;9:4906-4913.
16. ATHANASSIADOU P, GRAPSA D, GONIDI M, ATHANASSIADOU AM, TSIPIS A, PATSOURIS E. CD24 expression has a prognostic impact in breast carcinoma. Pathol Res Pract 2009;205:524-533.
17. BIRCAN S, KAPUCUOGLU N, BASPINAR S, INAN G, CANDIR O. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistrybased pilot study. Pathol Res Pract 2006;202:569-576.
18. ZHANG YH, WANG ZY, HAO FY, ZHANG L. Cluster of differentiation 24 monoclonal antibody induces apoptosis in the osteosarcoma cells. Eur Rev Med Pharmacol Sci 2014;18:2038-2041.
19. SU D, DENG H, ZHAO X, ZHANG X, CHEN L, CHEN X, LI Z, BAI Y, WANG Y, ZHONG Q, YI T, QIAN Z, WEI Y. Targeting CD24 for treatment of ovarian cancer by short hairpin RNA. Cytotherapy 2009;11:642-652.
20. JIAO XL, ZHAO C, NIU M, CHEN D. Downregulation of CD24 inhibits invasive growth, facilitates apoptosis and enhances chemosensitivity in gastric cancer AGS cells. Eur Rev Med Pharmacol Sci 2013;17:1709-1715.
21. KIM JB, KO E, HAN W, LEE JE, LEE KM, SHIN I, KIM S, LEE JW, CHO J, BAE JY, JEE HG, NOH DY. CD24 cross-linking induces apoptosis in, and inhibits migration of, MCF-7 breast cancer cells. BMC Cancer 2008;8:118.
22. SCHABATH H, RUNZ S, JOUMAA S, ALTEVOGT P. CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells. J Cell Sci 2006;119:314-325.
23. BAUMANN P, CREMERS N, KROESE F. CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis. Cancer Res 2005;65:10783-1093.
24. SUROWIAK P, MATERNA V, PALUCHOWSKI P, MATKOWSKI R, WOJNAR A, MACIEJCZYK A, PUDELKO M, KORNAFEL J, DIETEL M, KRISTIANSEN G, LAGE H, ZABEL M. CD24 expression is specific for tamoxifen-resistant ductal breast cancer cases. Anticancer Res 2006;26:629-634.
25. RODRIGUEZ LG, WU X, GUAN JL. Wound-healing assay. Methods Mol Biol 2005;29:23-29.
26. KRISTIANSEN G, SAMMAR M, ALTEVOGT P. Tumor biological aspects of CD24, a mucin-like adhesion molecule. J Mol Histol 2004;35:255-262.
27. SAGIV E, STARR A, ROZOVSKI U, KHOSRAVI R, ALTEVOGT P, WANG T, ARBER N. Targeting CD24 for treatment of colorectal and pancreatic cancer by monoclonal antibodies or small interfering RNA. Cancer Res 2008;68:2803-2812.
28. AIGNER S, STHOEGER ZM, FOGEL M. CD24, a mucintype glycoprotein, is a ligand for P-selectin on human tumor cells. Blood 1997;89:3385-3395.
29. SENNER V, STURM A, BAUR I, SCHRELL UH, DISTEL L, PAULUS W. CD24 promotes invasion of glioma cells in vivo. J Neuropathol Exp Neurol 2009;58:795-802.
30. EBCTCG. Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet 1998;351:1451-1462.